118 related articles for article (PubMed ID: 7561865)
41. Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF.
Semkova I; Schilling M; Henrich-Noack P; Rami A; Krieglstein J
Brain Res; 1996 Apr; 717(1-2):44-54. PubMed ID: 8738252
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex.
Obrenovitch TP; Zilkha E
Br J Pharmacol; 1996 Mar; 117(5):931-7. PubMed ID: 8851513
[TBL] [Abstract][Full Text] [Related]
43. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures.
Kristensen BW; Noraberg J; Zimmer J
Brain Res; 2001 Oct; 917(1):21-44. PubMed ID: 11602227
[TBL] [Abstract][Full Text] [Related]
44. NMDA-induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5-HT1A antagonist.
Dijk SN; Francis PT; Stratmann GC; Bowen DM
Br J Pharmacol; 1995 Aug; 115(7):1169-74. PubMed ID: 7582540
[TBL] [Abstract][Full Text] [Related]
45. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
46. Dose-dependent effect of S(+) ketamine on post-ischemic endogenous neurogenesis in rats.
Winkelheide U; Lasarzik I; Kaeppel B; Winkler J; Werner C; Kochs E; Engelhard K
Acta Anaesthesiol Scand; 2009 Apr; 53(4):528-33. PubMed ID: 19317867
[TBL] [Abstract][Full Text] [Related]
47. Prenatal exposure of rats to ammonia impairs NMDA receptor function and affords delayed protection against ammonia toxicity and glutamate neurotoxicity.
Miñana MD; Marcaida G; Grisolía S; Felipo V
J Neuropathol Exp Neurol; 1995 Sep; 54(5):644-50. PubMed ID: 7666052
[TBL] [Abstract][Full Text] [Related]
48. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
[TBL] [Abstract][Full Text] [Related]
49. Cerebroside-A provides potent neuroprotection after cerebral ischaemia through reducing glutamate release and Ca²⁺ influx of NMDA receptors.
Li L; Yang R; Sun K; Bai Y; Zhang Z; Zhou L; Qi Z; Qi J; Chen L
Int J Neuropsychopharmacol; 2012 May; 15(4):497-507. PubMed ID: 21557879
[TBL] [Abstract][Full Text] [Related]
50. Effects of volatile anesthetics on N-methyl-D-aspartate excitotoxicity in primary rat neuronal-glial cultures.
Kudo M; Aono M; Lee Y; Massey G; Pearlstein RD; Warner DS
Anesthesiology; 2001 Sep; 95(3):756-65. PubMed ID: 11575551
[TBL] [Abstract][Full Text] [Related]
51. Comparison of the potency of competitive NMDA antagonists against the neurotoxicity of glutamate and NMDA.
Speliotes EK; Hartnett KA; Blitzblau RC; Aizenman E; Rosenberg PA
J Neurochem; 1994 Sep; 63(3):879-85. PubMed ID: 7914224
[TBL] [Abstract][Full Text] [Related]
52. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
[TBL] [Abstract][Full Text] [Related]
53. Ifenprodil prevents glutamate cytotoxicity via polyamine modulatory sites of N-methyl-D-aspartate receptors in cultured cortical neurons.
Tamura Y; Sato Y; Yokota T; Akaike A; Sasa M; Takaori S
J Pharmacol Exp Ther; 1993 May; 265(2):1017-25. PubMed ID: 8098757
[TBL] [Abstract][Full Text] [Related]
54. Alterations of N-methyl-D-aspartate receptor properties after chemical ischemia.
Aizenman E; Sinor JD; Brimecombe JC; Herin GA
J Pharmacol Exp Ther; 2000 Nov; 295(2):572-7. PubMed ID: 11046090
[TBL] [Abstract][Full Text] [Related]
55. Neurotoxicity of polyamines and pharmacological neuroprotection in cultures of rat cerebellar granule cells.
Sparapani M; Dall'Olio R; Gandolfi O; Ciani E; Contestabile A
Exp Neurol; 1997 Nov; 148(1):157-66. PubMed ID: 9398458
[TBL] [Abstract][Full Text] [Related]
56. Neuroprotective effects of the N-methyl-D-aspartate receptor antagonists ifenprodil and SL-82,0715 on hippocampal cells in culture.
Shalaby IA; Chenard BL; Prochniak MA; Butler TW
J Pharmacol Exp Ther; 1992 Feb; 260(2):925-32. PubMed ID: 1346650
[TBL] [Abstract][Full Text] [Related]
57. Antihistamine terfenadine potentiates NMDA receptor-mediated calcium influx, oxygen radical formation, and neuronal death.
Díaz-Trelles R; Novelli A; Vega JA; Marini A; Fernández-Sánchez MT
Brain Res; 2000 Oct; 880(1-2):17-27. PubMed ID: 11032986
[TBL] [Abstract][Full Text] [Related]
58. N-methyl-D-aspartate releases gamma-aminobutyric acid from rat striatum in vivo: a microdialysis study using a novel preloading method.
Young AM; Bradford HF
J Neurochem; 1993 Feb; 60(2):487-92. PubMed ID: 8093478
[TBL] [Abstract][Full Text] [Related]
59. Brevetoxins cause acute excitotoxicity in primary cultures of rat cerebellar granule neurons.
Berman FW; Murray TF
J Pharmacol Exp Ther; 1999 Jul; 290(1):439-44. PubMed ID: 10381810
[TBL] [Abstract][Full Text] [Related]
60. Recruitment of GABAA inhibition in rat neocortex is limited and not NMDA dependent.
Ling DS; Benardo LS
J Neurophysiol; 1995 Dec; 74(6):2329-35. PubMed ID: 8747195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
